Deerfield Management Company »

Halozyme Therapeutics shares owned by Deerfield Management Company

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Deerfield Management Company from 13F filings

Historical chart of Deerfield Management Company investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Deerfield Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Deerfield Management Company

Quarter filed Position value Share count Share price at filing
2012-03-31 $57M 4.4M 12.76
2011-12-31 $62M 6.5M 9.51
2011-09-30 $43M 7.0M 6.14